首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase.
【24h】

Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase.

机译:四氢生物蝶呤而不是L-精氨酸会降低表达高水平内皮一氧化氮合酶的细胞中一氧化氮合酶的解偶联。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Endothelial NO synthase (eNOS) produces superoxide when depleted of (6R)-5,6,7,8-tetrahydro-L-biopterin (BH4) and L-arginine by uncoupling the electron flow from NO production. High expression of eNOS has been reported to have beneficial effects in atherosclerotic arteries after relatively short periods of time. However, sustained high expression of eNOS may have disadvantageous vascular effects because of uncoupling. We investigated NO and reactive oxygen species (ROS) production in a microvascular endothelial cell line (bEnd.3) with sustained high eNOS expression and absent inducible NOS and neuronal NOS expression using 4,5-diaminofluorescein diacetate and diacetyldichlorofluorescein as probes, respectively. Unstimulated cells produced both NO and ROS. After stimulation with vascular endothelial growth factor (VEGF), NO and ROS production increased. VEGF-induced ROS production was even further increased by the addition of extra L-arginine. Nomega-nitro-L-arginine methyl ester decreased ROS production. These findings strongly suggest that eNOS is a source of ROS in these cells. Although BH4 levels were increased as compared with another endothelial cell line, eNOS levels were >2 orders of magnitude higher. The addition of BH4 resulted in increased NO production and decreased generation of ROS, indicating that bEnd.3 cells produce ROS through eNOS uncoupling because of relative BH4 deficiency. Nevertheless, eNOS-dependent ROS production was not completely abolished by the addition of BH4, suggesting intrinsic superoxide production by eNOS. This study indicates that potentially beneficial sustained increases in eNOS expression and activity could lead to eNOS uncoupling and superoxide production as a consequence. Therefore, sustained increases of eNOS or VEGF activity should be accompanied by concomitant supplementation of BH4.
机译:内皮型一氧化氮合酶(eNOS)通过将电子流与一氧化氮的产生解耦而耗尽(6R)-5,6,7,8-四氢-L-生物蝶呤(BH4)和L-精氨酸时会产生超氧化物。据报道,eNOS的高表达在相对较短的时间后对动脉粥样硬化动脉具有有益作用。然而,由于未偶联,持续高表达eNOS可能对血管产生不利影响。我们调查了微血管内皮细胞系(bEnd.3)中NO和活性氧(ROS)的产生,这些细胞系分别使用4,乙酸二氨基荧光素二乙酸酯和二乙酰基二氯荧光素作为探针,持续具有较高的eNOS表达而没有可诱导的NOS和神经元NOS表达。未刺激的细胞同时产生NO和ROS。用血管内皮生长因子(VEGF)刺激后,NO和ROS产生增加。通过添加额外的L-精氨酸,VEGF诱导的ROS产生甚至进一步增加。 Nomega-硝基-L-精氨酸甲酯降低了ROS的产生。这些发现强烈表明,eNOS是这些细胞中ROS的来源。尽管与另一种内皮细胞系相比,BH4水平升高,但eNOS水平却高出2个数量级。 BH4的添加导致NO产生增加和ROS生成减少,表明bEnd.3细胞由于相对BH4缺乏而通过eNOS解偶联产生ROS。然而,通过添加BH4并不能完全消除依赖eNOS的ROS产生,这表明eNOS可以产生固有的超氧化物。这项研究表明,eNOS表达和活性的潜在有益持续增加可能导致eNOS解偶联和超氧化物产生。因此,eNOS或VEGF活性的持续增加应伴有BH4的补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号